Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia
Status:
Unknown status
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to ascertain the safety and efficacy of
Clobetasol Propionate 0.05% E Foam in the treatment of Central Centrifugal
Cicatricial Alopecia.